LRP1 in Brain Vascular Smooth Muscle Cells Mediates Local Clearance of Alzheimer's Amyloid-β
Open Access
- 14 November 2012
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 32 (46), 16458-16465
- https://doi.org/10.1523/jneurosci.3987-12.2012
Abstract
Impaired clearance of amyloid-β (Aβ) is a major pathogenic event for Alzheimer's disease (AD). Aβ depositions in brain parenchyma as senile plaques and along cerebrovasculature as cerebral amyloid angiopathy (CAA) are hallmarks of AD. A major pathway that mediates brain Aβ clearance is the cerebrovascular system where Aβ is eliminated through the blood–brain barrier (BBB) and/or degraded by cerebrovascular cells along the interstitial fluid drainage pathway. An Aβ clearance receptor, the low-density lipoprotein receptor-related protein 1 (LRP1), is abundantly expressed in cerebrovasculature, in particular in vascular smooth muscle cells. Previous studies have indicated a role of LRP1 in endothelial cells in transcytosing Aβ out of the brain across the BBB; however, whether this represents a significant pathway for brain Aβ clearance remains controversial. Here, we demonstrate that Aβ can be cleared locally in the cerebrovasculature by an LRP1-dependent endocytic pathway in smooth muscle cells. The uptake and degradation of both endogenous and exogenous Aβ were significantly reduced in LRP1-suppressed human brain vascular smooth muscle cells. Conditional deletion ofLrp1in vascular smooth muscle cell in amyloid model APP/PS1 mice accelerated brain Aβ accumulation and exacerbated Aβ deposition as amyloid plaques and CAA without affecting Aβ production. Our results demonstrate that LRP1 is a major Aβ clearance receptor in cerebral vascular smooth muscle cell and a disturbance of this pathway contributes to Aβ accumulation. These studies establish critical functions of the cerebrovasculature system in Aβ metabolism and identify a new pathway involved in the pathogenesis of both AD and CAA.Keywords
This publication has 59 references indexed in Scilit:
- Neuroprotective strategies involving ROS in Alzheimer diseaseFree Radical Biology & Medicine, 2011
- Amyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutationsJournal of Neuroscience Methods, 2011
- Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ ClearancePublished by Elsevier BV ,2010
- Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptideProceedings of the National Academy of Sciences of the United States of America, 2009
- Receptor-associated Protein Interacts with Amyloid-β Peptide and Promotes Its Cellular UptakePublished by Elsevier BV ,2009
- Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapyNature Reviews Neuroscience, 2009
- Selective targeting of perivascular macrophages for clearance of β-amyloid in cerebral amyloid angiopathyProceedings of the National Academy of Sciences of the United States of America, 2009
- SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cellsNature, 2008
- Amyloid Precursor Protein Regulates Brain Apolipoprotein E and Cholesterol Metabolism through Lipoprotein Receptor LRP1Neuron, 2007
- Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous SystemJournal of Cerebral Blood Flow & Metabolism, 2006